Resveratrol

Polyphenol from red wine and Japanese knotweed, preclinically prolific, clinically disappointing, and often asked about as a longevity compound though no human evidence supports that.

Evidence
Preliminary evidenceGRADE certainty: Very low
Typical dose
150–500 mg/day
Time to effect
Biomarker changes over weeks
Safety
Has documented cautions

Evidence ratings summarise published research on Resveratrol in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Resveratrol

Interactions

Taking any medication?

Check Resveratrol against it.

Why

Resveratrol (trans-3,5,4'-trihydroxystilbene) is the polyphenol from red wine, grapes and Japanese knotweed that triggered the modern longevity-supplement field after sirtuin-activating publications in the 2000s. Despite extensive preclinical work, human evidence has largely been disappointing: a review of 11 meta-analyses of human trials found no significant effect on cognition, mood or blood pressure, and resveratrol added no benefit to nicotinamide riboside in peripheral artery disease. Small short RCTs report changes in vascular function in older adults with impaired glucose regulation, androgens in PCOS, and metabolic markers in a few obese men. No human trial shows a longevity or healthspan benefit. Bioavailability is poor and a fundamental clinical limit.

How it works

Sirtuin-1 activation (originally proposed mechanism, contested). AMPK activation. Endothelial nitric oxide synthase modulation. PDE4 inhibition. The proposed 'caloric restriction mimetic' framing has not been confirmed in clinical trials.

Expected onset · Biomarker changes over weeks; clinical endpoints not consistently demonstrated

How to take

Dosage

150–500 mg/day. Trials use a wide range (75–1,500 mg/day). Higher doses do not consistently improve outcomes.

Timing

With meals containing fat for absorption

On the label

trans-resveratrol (the bioactive isomer) with stated mg per dose. Often from Japanese knotweed (Polygonum cuspidatum) rather than grape, chemically equivalent. Micronised or liposomal forms have marginally better absorption.

Studied in

Adults curious about resveratrol who want realistic expectations, since no human evidence supports a longevity benefit.

Safety

Mild GI upset at higher doses. Theoretical antiplatelet effect. Caution with anticoagulants. Possible CYP3A4 and CYP2C9 inhibition at high doses, interaction with statins, warfarin. Pregnancy and breastfeeding: limited data; avoid. Bioavailability of oral resveratrol is poor (<1% systemic), much of what's swallowed is glucuronidated and excreted.
Loading interactions…

Evidence

At a glance

Khorshidi 2021 Ageing Research Reviews (11 meta-analyses of human trials): no significant effect on cognition, mood or blood pressure. Small RCTs found other changes: better vascular function in older adults with impaired glucose regulation (n=30), lower androgens in women with PCOS, and altered metabolic markers in 11 obese men. Resveratrol added no benefit to nicotinamide riboside in peripheral artery disease.

GRADE certainty: Very low — rated by Healicus using the GRADE method

Limitations

The gap between extensive preclinical promise and disappointing or inconsistent clinical results is the central honest framing for resveratrol. No Cochrane review, no EMA monograph, no EFSA-authorised claim. Bioavailability of oral resveratrol is the fundamental limit.

Questions people ask

Does Resveratrol work?

Khorshidi 2021 Ageing Research Reviews (11 meta-analyses of human trials): no significant effect on cognition, mood or blood pressure. Small RCTs found other changes: better vascular function in older adults with impaired glucose regulation (n=30), lower androgens in women with PCOS, and altered metabolic markers in 11 obese men. Resveratrol added no benefit to nicotinamide riboside in peripheral artery disease. Certainty of the evidence: Very low, rated by Healicus using the GRADE method.

How is Resveratrol taken?

150–500 mg/day. Trials use a wide range (75–1,500 mg/day). Higher doses do not consistently improve outcomes. Timing: With meals containing fat for absorption. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Mild GI upset at higher doses. Theoretical antiplatelet effect. Caution with anticoagulants. Possible CYP3A4 and CYP2C9 inhibition at high doses, interaction with statins, warfarin. Pregnancy and breastfeeding: limited data; avoid. Bioavailability of oral resveratrol is poor (<1% systemic), much of what's swallowed is glucuronidated and excreted. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Khorshidi F et al., Resveratrol: A "miracle" drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis, Ageing Res Rev 2021; Semba RD et al., Resveratrol levels and all-cause mortality in older community-dwelling adults, JAMA Intern Med 2014; Pollack RM et al., Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults, J Gerontol A Biol Sci Med Sci 2017; Banaszewska B et al., Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial, J Clin Endocrinol Metab 2016; Timmers S et al., Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans, Cell Metab 2011; McDermott MM et al., Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial, Nat Commun 2024.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.